| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |